Current position:Home >Product >
N-[4-[3-(2,6-DiaMino-1,4-dihydro-4-oxo-5-pyriMidinyl)-3-oxopropyl]benzoyl]-L-glutaMic Acid
N-[4-[3-(2,6-DiaMino-1,4-dihydro-4-oxo-5-pyriMidinyl)-3-oxopropyl]benzoyl]-L-glutaMic Acid(193281-05-9)
- Name: N-[4-[3-(2,6-DiaMino-1,4-dihydro-4-oxo-5-pyriMidinyl)-3-oxopropyl]benzoyl]-L-glutaMic Acid
- Synonyms:N-[4-[3-(2,6-Diamino-1,4-dihydro-4-oxo-5-pyrimidinyl)-3-oxopropyl]benzoyl]-L-glutamic Acid;
- Molecular Formula:C19H21N5O7
- Molecular Weight:431.4
- CAS Registry Number:193281-05-9
- EINECS:
- Melting Point:>150°C (dec.)
- Water Solubility:
CAS No.193281-05-9 N-[4-[3-(2,6-DiaMino-1,4-dihydro-4-oxo-5-pyriMidinyl)-3-oxopropyl]benzoyl]-L-glutaMic Acid
Assay:99% Package:According to customer requirements Transportation:By Sea/Air/Courier Application:medicine
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] 
Assessed
SupplierTel:86-15965530500
Address:Room1701, Tianxing Building,Licheng district, jinan, Shandong, China
- Contact Suppliers
Other Product
- 102822-04-8/1-nitropyrene-4,5-dione
- 35498-95-4/2-[2-[[5,6-dimethoxy-3-(3-sulphonatopropyl)-(3H)-benzoselenazol-2-ylidene]methyl]but-1-enyl]-3-ethyl-5,6-dimethylbenzoselenazolium
- 13981-83-4/(~61~Co)cobalt
- 110076-61-4/1-[(4-bromobutoxy)methyl]-2,4,5-trichloro-1H-imidazole
- 161842-83-7/b-D-Galactopyranoside, (3b,4a,16b)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl O-b-D-glucopyranosyl-(1®2)-O-[O-b-D-glucopyranosyl-(1®4)-b-D-glucopyranosyl-(1®3)]-6-deoxy- (9CI)
- 57639-22-2/4-Chloro-6-ethyl-N-(1-methylethyl)-1,3,5-triazin-2-amine
- 308-48-5/PERFLUORODIBUTYLETHER
- 10199-85-6/2,4-DICHLORO-1,3-DINITROBENZENE
- 133764-38-2/2,3-dimethylbutyl nitrate
- 3734-26-7/1-Methyl-1-(1-methyl-2-phenylethyl)hydrazine
- 41928-09-0/Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.-methylenebis4-(1,1,3,3-tetramethylbutyl)-2,1-phenylenebis.omega.-hydroxy-
- 5504-71-2/N-[4-chloro-2-(phenylcarbonyl)phenyl]glycinamide
- 63870-02-0/2-methyl-1,5-benzothiazepin-4(5H)-one
- 49603-78-3/Acetic acid ethenyl ester, polymer with ethene, N-(hydroxymethyl)-2-propenamide and 2-propenamide
- 102466-31-9/2-(diethylamino)ethyl (2-butoxyquinolin-4-yl)carbamate
- 20052-17-9/2-morpholin-4-yl-4-oxo-1-phenyl-5H-pyrrole-3-carbonitrile
- 59481-55-9/Actinomycin D, 3A- (2-azetidinecarboxylic acid)-3B-(2-azetidinecarboxylic acid)-
- 7243-51-8/ethyl 1-{6-[(2-ethoxy-2-oxoethyl)carbamoyl]-2-pyridin-2-yl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl}piperidine-4-carboxylate
- 6428-38-2/2-Naphthalenesulfonic acid, 6-[[2-amino-4-[(2-hydroxyethyl)amino]phenyl]azo]-3-[[4-[[4-[[7-[[2-amino-4-[(2-hydroxyethyl)amino]phenyl]azo]-1-hydroxy-3-sulfo-2-naphthalenyl]azo]phenyl]amino]-3-sulfophenyl]azo]-4-hydroxy-, trisodium salt
- 193281-05-9/N-[4-[3-(2,6-DiaMino-1,4-dihydro-4-oxo-5-pyriMidinyl)-3-oxopropyl]benzoyl]-L-glutaMic Acid
- 180288-69-1/Trastuzumab
- 130252-51-6/4H-1-Benzopyran-4-one,2,3-dihydro-7-hydroxy-2-[2-hydroxy-4-methoxy-5-(3-methyl-2-buten-1-yl)phenyl]-8-(3-methyl-2-buten-1-yl)-,(2S)-
- 58892-69-6/2-Phenyl-3-[(4-phenyl-1-piperazinyl)methyl]-1-methylindolizine
- 201-42-3/13H-benzo[k]cyclopenta[pqr]tetraphene
- 77327-46-9/oxytocin, 1-(1-mercaptocyclohexaneacetic acid)-(OEt-Tyr)(2)-Orn(8)-
- 38246-95-6/N-hydroxyphenetidine
- 7510-32-9/diphenyl[2-(propan-2-yl)phenyl]methanol
- 15223-20-8/4-Methylbenzene-1-thiosulfonic acid S-trifluoromethyl ester
- 1189-11-3/N5-[imino(phosphonoamino)methyl]L-ornithine
- 436811-25-5/3-(PYRROLIDINE-1-CARBONYL)-BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID